Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
11/2010
11/11/2010US20100286125 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
11/10/2010CN101085041B Total alkaloid of lotus leaves extraction and its preparation method
11/04/2010WO2010127307A1 Antimicrobial agents
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010125343A1 Compounds for inducing cellular apoptosis
11/04/2010US20100280067 Inhibitors of acetyl-coa carboxylase
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100280011 Dual mechanism inhibitors for the treatment of disease
11/04/2010CA2760611A1 Dual-action inhibitors and methods of using same
11/04/2010CA2760562A1 Dual mechanism inhibitors for the treatment of disease
11/04/2010CA2760526A1 Antimicrobial agents
11/03/2010EP1805155B1 Thrombopoietin activity modulating compounds and methods
11/03/2010EP1487795B1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
11/02/2010US7825109 Compound capable of binding S1P receptor and pharmaceutical use thereof
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2009118765A3 Novel monoamine re-uptake inhibitor
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/26/2010US7820692 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/26/2010US7820675 Benzofuran compounds
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267767 Nuclear receptor binding agents
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267697 Ion channel modulators
10/20/2010EP2240450A1 Trpa1 antagonists
10/19/2010US7816371 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816352 Apoptosis inhibitors
10/19/2010CA2286722C Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
10/14/2010WO2010117090A1 Novel isoquinolinyloxymethyl heteroaryl derivatives
10/14/2010WO2010117084A1 Novel isoquinoline derivatives
10/14/2010WO2010116915A1 Cyclic compound having substituted phenyl group
10/14/2010WO2009044019A9 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
10/14/2010WO2009044018A9 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010CA2758144A1 Cyclic compound having substituted phenyl group
10/12/2010US7812019 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
10/12/2010US7811681 Electron transport compound and organic light emitting device comprising the same
10/07/2010WO2010114107A1 Actinic ray-sensitive or radiation-sensitive resin composition and pattern forming method using the same
10/07/2010US20100256698 Isoquinolinone Potassium Channel Inhibitors
10/07/2010US20100256182 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256101 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
10/07/2010US20100255418 Actinic-ray- or radiation-sensitive resin composition and method of forming pattern therewith
10/06/2010EP2236495A1 New salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN101851200A Synthetic method of 1-phenyl-1,2,3,4-tetrahydroisoquinoline
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807693 e.g. 4-methoxy-pyrrolidine-1,2-dicarboxylic acid-1-[(4-chloro-phenyl)-amide]-2-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide; factor Xa and related serine proteases inhibitor; anticoagulant, thrombolytic agent
09/2010
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010078449A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249024 Cetp inhibitors
09/30/2010US20100248313 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2231155A1 Tetrahydroisoquinoline derivatives
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/29/2010CN101848896A Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
09/29/2010CN101845017A Preparation method of atracurium besilate intermediates
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/21/2010US7799819 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/16/2010WO2010103529A1 A new method for the preparation of solifenacin and new intermediate thereof
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010WO2009138712A3 Chemical compounds
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/15/2010EP2228363A1 Kit for use in production of molecular probe for pet drug screening
09/15/2010EP2227455A1 Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
09/15/2010EP2227454A2 Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative
09/15/2010CN101829598A Preparation method of acetylated glycosyl thiourea derivative and application thereof in isoquinoline acid synthesis
09/14/2010US7795278 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof
09/14/2010CA2394276C Serine protease inhibitors
09/10/2010WO2009118765A8 Novel monoamine re-uptake inhibitor
09/09/2010US20100227978 Metal complexes
09/08/2010EP2225207A2 Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents
09/08/2010EP0882717B1 Nitrogenous heterocyclic compounds
09/08/2010CN1968929B Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/07/2010US7790743 Modulators of cellular adhesion
09/07/2010US7790742 6,8-dichloro-2-methyl-4-[4N-(2-ethoxy-3,4-dioxocyclobuten-1-yl)amino]phenyl-1,2,3,4-tetrahydroisoquinoline, used as regulators of the intracellular pH environment, transport protein and carbonic anhydrase inhibitors; treatment of urogenital, respiratory system, cardiovascular and nervous system disorders
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010CA2539729C Isoquinolinone potassium channel inhibitors
09/02/2010US20100222330 New Compounds
09/02/2010US20100222299 Compound
09/01/2010EP2222671A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP2222641A1 A new inhibitor of dd-peptidase and its use as antibiotic or anticancer drug
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 119